This virtual and in-person symposium is presented by AIM at Melanoma and UPMC Hillman Cancer Center held at UPMC Hillman Cancer Center.
UPMC Hillman Cancer Center is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center. They offer cancer care, research, and education for cancer researchers.
Date: Saturday, March 16, 2024
Time: 8:00 AM (ET)| 7:00 AM (CT) | 6:00 AM (MT) | 5:00 AM (PT)
Format: Presented both virtually and in-person
Presentadores y temas
8:30 AM ET
Welcome & Opening Remarks
John M. Kirkwood, MD
Distinguished Service Professor of Medicine
Usher Professor of Medicine, Dermatology and Translational Science
Co-Leader, Melanoma and Skin Cancer Program
UPMC Hillman Cancer Center
Each presentation includes a 5-minute Q & A Session
8:40 AM ET
Management of Side Effects for BRAF/MEK Inhibitors
Dominic Anthony DeSalle, PA-C
Physician Assistant, Senior
UPMC Hillman Cancer Center
9:05 AM ET
Preventative Skin Care
Darcy Ploucha, PA-C, MPAS
Physician Assistant, Senior
UPMC Hillman Cancer Center
9:30 AM ET
Tissue Banking: Samples are Only Part of the Issue. What About the Data?
Mary Horak, BS, CCRP
Clinical Research Services
UPMC Hillman Cancer Center
9:55 AM ET
Can We Predict Who Will Respond to Immunotherapy?
Yana Najjar, MD
Assistant Professor of Medicine
UPMC Hillman Cancer Center
10:30 AM ET
Role of Diet and Gut Microbiota in Determining Response and irAEs
Diwakar Davar, MD
Assistant Professor of Medicine
UPMC Hillman Cancer Center
10:55 AM ET
Pediatric Melanoma – The Time is Now for a Standard Treatment Approach
Brittani Seynnaeve, MD, MS
Associate Fellowship Program Director
Pediatric Melanoma Program Director
Division of Pediatric Hematology/Oncology, Department of Pediatrics
UPMC Children’s Hospital of Pittsburgh